Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 16428, 2024 Jul 16.
Article in English | MEDLINE | ID: mdl-39013961

ABSTRACT

Studies investigating the relationship between dietary vitamin B1 intake and risk of Hyperuricemia (HU) are scarce, the present study aimed to examine the association of dietary vitamin B1 intake and HU among adults. This cross-sectional study included 5750 adults whose data derived from National Health and Nutrition Examination Survey (NHANES) from March 2017 to March 2020. The dietary intake of vitamin B1 was assessed using 24-h dietary recall interviews. The characteristics of study participants were grouped into five levels according to the levels of vitamin B1 quintile. Multivariate logistic regression analysis was used to estimate the odds ratio (OR) and 95% confidence interval (CI) of HU, according to the vitamin B1 intake quintile for male and female separately. The dose-response relationship was determined by the restricted cubic spline (RCS). Smoothed curve fitting was used to assess serum uric acid concentration versus dietary vitamin B1 intake in the study population. The prevalence of hyperuricemia was 18.90% (20.15% and 17.79% for males and females, respectively) in the United States from March 2017 to March 2020. Multiple logistic regression analyses showed that in the male population, the HU ratio (OR) of vitamin B1 intake in Q2 to Q5 compared with the lowest quintile (Q1) was 0.75 (95% CI 0.52, 1.09), 0.70 (95% CI 0.48, 1.02), 0.66 (95% CI 0.44, 0.99) and 0.55 (95% CI 0.34, 0.90). The P for trend was 0.028. In women, the ORs for vitamin B1 intake Q2 to Q5 were 0.87 (95% CI 0.64, 1.19), 0.97 (0.68-1.38), 1.05 (0.69-1.60) and 0.75 (0.42-1.34), respectively. The P for trend was 0.876. The RCS curve revealed a linear relationship between vitamin B1 intake and the risk of hyperuricemia in men (P nonlinear = 0.401). Smoothed curve fitting demonstrated a negative association between vitamin B1 intake and serum uric acid concentration in men, whereas there was no significant association between dietary vitamin B1 intake and the risk of hyperuricemia in women. In the US adult population, dietary vitamin B1 intake was negatively associated with hyperuricemia in males.


Subject(s)
Hyperuricemia , Nutrition Surveys , Thiamine , Uric Acid , Humans , Hyperuricemia/epidemiology , Hyperuricemia/blood , Hyperuricemia/etiology , Male , Female , Middle Aged , Adult , Cross-Sectional Studies , Uric Acid/blood , Thiamine/administration & dosage , Thiamine/blood , Prevalence , Diet , Odds Ratio , Risk Factors , Aged , United States/epidemiology
2.
Br J Cancer ; 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38906969

ABSTRACT

BACKGROUND: Lipid droplet formation is a prominent histological feature in clear cell renal cell carcinoma (ccRCC), but the significance and mechanisms underlying lipid droplet accumulation remain unclear. METHODS: Expression and clinical significance of MT1G in ccRCC were analyzed by using TCGA data, GEO data and scRNASeq data. MT1G overexpression or knockdown ccRCC cell lines were constructed and in situ ccRCC model, lung metastasis assay, metabolomics and lipid droplets staining were performed to explore the role of MT1G on lipid droplet accumulation in ccRCC. RESULTS: Initially, we observed low MT1G expression in ccRCC tissues, whereas high MT1G expression correlated with advanced disease stage and poorer prognosis. Elevated MT1G expression promoted ccRCC growth and metastasis both in vitro and in vivo. Mechanistically, MT1G significantly suppressed acylcarnitine levels and downstream tricarboxylic acid (TCA) cycle activity, resulting in increased fatty acid and lipid accumulation without affecting cholesterol metabolism. Notably, MT1G inhibited H3K14 trimethylation (H3K14me3) modification. Under these conditions, MT1G-mediated H3K14me3 was recruited to the CPT1B promoter through direct interaction with specific promoter regions, leading to reduced CPT1B transcription and translation. CONCLUSIONS: Our study unveils a novel mechanism of lipid droplet accumulation in ccRCC, where MT1G inhibits CPT1B expression through modulation of H3K14 trimethylation, consequently enhancing lipid droplet accumulation and promoting ccRCC progression. Graphical abstract figure Schematic diagram illustrating MT1G/H3K14me3/CPT1B-mediated lipid droplet accumulation promoted ccRCC progression via FAO inhibition.

3.
Heliyon ; 10(1): e23833, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-38261922

ABSTRACT

Betulinic acid (BA) is a pentacyclic triterpene found in many plant species and has a broad-spectrum anti-tumor effect in various cancers, including colon cancer (CRC). However, its anticancer mechanism in CRC is no clear. RNA sequencing and bioinformatics analysis showed BA up-regulated 378 genes and down-regulated 137 genes in HT29 cells, while 2303 up-regulated and 1041 down-regulated genes were found in SW480 cells. KEGG enrichment analysis showed BA significantly stimulated the expression of metallothionein 1 (MT1) family genes in both HT29 and SW480 cells. Metallothionein 1G (MT1G) was the gene with the highest upregulation of MT1 family genes induced by BA dose-dependently. High MT1G expression enhanced the sensitivity of CRC cells to BA, whereas, MT1G knockdown had the opposite effect in vitro and in vivo. GSEA and GSCA showed genes affected by BA treatment were involved in cell cycle and G2/M checkpoint in CRC. Flow cytometry further exhibited BA reduced the percentage of G0/G1 cells and increased the percentage of G2/M cells in a dose-dependent manner, which could be rescued by MT1G knockdown. Moreover, MT1G also counteracted the BA-induced changes in cell cycle-related proteins (CDK2 and CDK4) and p-Rb. In summary, we have revealed a new anti-tumor mechanism that BA altered the cell cycle progression of CRC cells by upregulating MT1G gene, thereby inhibiting the proliferation of CRC cells.

4.
Adv Healthc Mater ; 13(10): e2302833, 2024 04.
Article in English | MEDLINE | ID: mdl-38185787

ABSTRACT

Osteoarthritis (OA) is a highly prevalent and intricate degenerative joint disease affecting an estimated 500 million individuals worldwide. Collagen-based hydrogels have sparked immense interest in cartilage tissue engineering, but substantial challenges persist in developing biocompatible and robust crosslinking strategies, as well as improving their effectiveness against the multifaceted nature of OA. Herein, a novel discovery wherein the simple incorporation of ferrous/ferric ions enables efficient dynamic crosslinking of type II collagen, leading to the development of injectable, self-healing hydrogels with 3D interconnected porous nanostructures, is unveiled. The ferrous/ferric ions crosslinked type II collagen hydrogels demonstrate exceptional physical properties, such as significantly enhanced mechanical strength, minimal swelling ratios, and remarkable resistance to degradation, while also exhibiting extraordinary biocompatibility and bioactivity, effectively promoting cell proliferation, adhesion, and chondrogenic differentiation. Additionally, the hydrogels reveal potent anti-inflammatory effects by upregulating anti-inflammatory cytokines while downregulating pro-inflammatory cytokines. In a rat model of cartilage defects, these hydrogels exhibit impressive efficacy, substantially accelerating cartilage tissue regeneration through enhanced collagen deposition and increased proteoglycan secretion. The innovative discovery of the multifunctional role of ferrous/ferric ions in endowing type II collagen hydrogels with a myriad of beneficial properties presents exciting prospects for developing advanced biomaterials with potential applications in OA.


Subject(s)
Hydrogels , Osteoarthritis , Rats , Animals , Hydrogels/pharmacology , Hydrogels/chemistry , Collagen Type II , Collagen/chemistry , Tissue Engineering , Anti-Inflammatory Agents , Cytokines , Osteoarthritis/drug therapy , Ions
5.
Am J Cancer Res ; 13(8): 3482-3499, 2023.
Article in English | MEDLINE | ID: mdl-37693144

ABSTRACT

Angiogenesis is essential for the growth and metastasis of several malignant tumors including colorectal cancer (CRC). The molecular mechanism underlying CRC angiogenesis has not been fully elucidated. Emerging evidence indicates that secreted microRNAs (miRNAs) may mediate the intercellular communication between tumor cells and neighboring endothelial cells to regulate tumor angiogenesis. In addition, exosomes have been shown to carry and deliver miRNAs to regulate angiogenesis. miRNA N-72 is a novel miRNA that plays a regulatory role in the EGF-induced migration of human amnion mesenchymal stem cells. However, the relation between miRNA N-72 and cancer remains unclear. We here found that CRC cells could secrete miRNA N-72. A high miRNA N-72 level was detected in the serum of CRC patients and the cultured CRC cells. Moreover, the CRC cell-secreted miRNA N-72 could promote the migration, tubulogenesis, and permeability of endothelial cells. In addition, the mouse xenograft model was used to verify the facilitating effects of miRNA N-72 on CRC growth, angiogenesis, and metastasis in vivo. Further mechanism analysis revealed that CRC cell-secreted miRNA N-72 could be delivered into endothelial cells via exosomes, which then inhibited cell junctions of endothelial cells by targeting CLDN18 and consequently promoted angiogenesis. Our findings reveal a novel mechanism of CRC angiogenesis and highlight the potential of secreted miRNA N-72 as a therapeutic target and a biomarker for CRC.

6.
Environ Sci Pollut Res Int ; 30(43): 97298-97309, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37589845

ABSTRACT

Chitosan-stabilized iron-copper nanomaterials (CS-nZVI/Cu) were successfully prepared and applied to the nitrate removal. Batch experiments were conducted to examine the effects of experimental parameters on nitrate removal, including Cu loading, CS-nZVI/Cu dosages, initial nitrate concentrations, and initial pHs. From the experimental date, it was concluded that CS-nZVI/Cu has a high nitrate removal efficiency, which can be more than 97%, respectively, at Cu loading = 5%, dosages of CS-nZVI/Cu = 3 g/L, initial nitrate concentrations of 30~120 mg/L, and initial pH values = 2~9. Additionally, the kinetic data for CS-nZVI/Cu were found to fit well with the first-order kinetic model with a rate constant of 0.15 (mg∙L)1-n/min, where n=1. The Langmuir model showed a good fit for NO3- removal, indicating that monolayer chemisorption occurred. The SEM and TEM analyses showed that the addition of chitosan resulted in improved dispersion of the CS-nZVI/Cu. The CS-nZVI/Cu nanomaterials have a more complete elliptical shape and are between 50 and 100 nm in size. The XRD analysis showed that the chitosan encapsulation reduced the oxidation of the iron component and the main product was Fe3O4. The FT-IR analysis showed that the immobilization of chitosan and the iron was accomplished by the ligand interaction. The nitrogen adsorption-desorption isotherm results showed that the CS-nZVI/Cu specific surface area and pore volume decreased significantly after the reaction. Adsorption, oxidation, and reduction are possible mechanisms for nitrate removal by CS-nZVI/Cu. The XPS analysis investigated the contribution of nZVI and Cu in the removal mechanism. Adding copper accelerates the reaction time and rate. In addition, nZVI played a vital role in reducing nitrate to N2. Based on these results, it looks like CS-nZVI/Cu could be a satisfactory material for nitrate removal.


Subject(s)
Chitosan , Nanoparticles , Nitrates , Copper , Spectroscopy, Fourier Transform Infrared , Iron
7.
Stem Cells Int ; 2020: 3296192, 2020.
Article in English | MEDLINE | ID: mdl-32724313

ABSTRACT

Gastric cancer is the third most common type of tumor associated with death. TRAF6 belongs to the tumor necrosis factor receptor-associated factor family and has been demonstrated to be involved in tumor progression in various cancers. However, the exact effect of TRAF6 on gastric cancer stem cells has not been extensively studied. In this study, abnormal expression of TRAF6 was found in gastric cancer tissues. Overexpression of TRAF6 enhanced proliferation and migration, and TRAF6 knockdown reversed this phenomenon in gastric cancer cells. Moreover, TRAF6 may inhibit differentiation and promote stemness and epithelial-mesenchymal transition (EMT). Transcriptome profiles revealed 701 differentially expressed genes in the wild-type group and the TRAF6 knockout group. Potential molecules associated with cell proliferation and migration were identified, including MAPK, FOXO, and IL-17. In conclusion, TRAF6 is a significant factor promoting proliferation and migration in gastric cancer cells and may provide a new target for the accurate treatment of gastric cancer.

8.
Water Sci Technol ; 77(3-4): 1098-1106, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29488973

ABSTRACT

The spectral and charged characteristics of dissolved organic matter (DOM) in municipal sewage secondary effluent influenced by heavy metal ions were studied by three-dimensional fluorescence spectroscopy, ultraviolet spectrometry, etc. As the Cu(II) concentration increased, the fluorescence intensity of the DOM's fluorescence peak reduced. When the Cu(II) concentration was 100 µmol/L, the fluorescence intensity of the humic-like acid in the DOM reduced by 19.5%-27.6%. However, there was no obvious change in the fluorescence intensity when Cd(II) was added. According to the modified Stern-Volmer equation, the conditional stability constant lgK and the proportion of the fluorescent functional groups of the DOM binding with Cu(II) were 2.19-2.69 and 16%-48%, respectively. The UV253/UV203 value changed little with the additional dosage of metal ions below 10 µmol/L, which increased as the concentration of Cu(II) or Pb(II) increased from 10-100 µmol/L. As the metal concentrations increase, the absolute values of the Zeta potential and the particle sizes of the DOM basically increased. The results showed that Cu(II) had the strongest binding ability to the groups that emitted fluorescence in the secondary effluent DOM compared to Pb(II) and Cd(II).


Subject(s)
Metals, Heavy/analysis , Sewage/analysis , Water Pollutants/analysis , Metals, Heavy/chemistry , Spectrometry, Fluorescence/methods , Water Pollutants/chemistry
9.
Talanta ; 176: 308-317, 2018 Jan 01.
Article in English | MEDLINE | ID: mdl-28917756

ABSTRACT

The Cu2+-decorated functional mesoporous material was fabricated by thermally initiated free-radical polymerization of octavinyl polyhedral oligomeric silsesquioxane. It was used as adsorbent for highly specific separation of histidine (His)-rich proteins in blood and cell lysate based on immobilized metal affinity chromatography. The functional mesoporous material (named as PPOSS-IDA-Cu2+) was characterized in detail and its selectivity and binding capacity were evaluated using a His-rich protein (bovine hemoglobin, BHb) and other proteins (bovine serum albumin, myoglobin, lysozyme and horseradish peroxidase) containing fewer surface-exposed His residues as model proteins. The results indicated that PPOSS-IDA-Cu2+ exhibited large specific surface area and good selective adsorption ability and the maximum adsorption capacity for BHb was 3150mgg-1. Moreover, PPOSS-IDA-Cu2+ had excellent recyclability and the adsorption capacity of the reused material for BHb remained almost unchanged after six cycles. In addition, PPOSS-IDA-Cu2+ not only showed excellent performance for the removal of highly abundant hemoglobin in human blood, but also can be a good adsorbent for the enrichment of proteins in cell lysate. It was the first time to explore the application of Cu2+-decorated functional material as an adsorbant for the separation of proteins in cell lysate. This approach can be combined with other techniques which can remove or deplete highly abundant proteins from real biological samples to obtain more comprehensive data about low abundant His-rich proteins in proteomic analysis.


Subject(s)
Copper/chemistry , Hemoglobins/chemistry , Organosilicon Compounds/chemistry , Adsorption , Cell Line, Tumor , Horseradish Peroxidase/chemistry , Humans , Imino Acids/chemistry , Muramidase/chemistry , Myoglobin/chemistry , Polymers/chemistry , Serum Albumin, Bovine/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...